Noscapine Syrup, marketed under the brand name pd NOSCA, is a specialized Finished Dosage Form (FDF) manufactured by Parand Darou Co. Containing 7 mg of Noscapine per 5 ml, this product is a potent non-narcotic antitussive. It acts centrally on the cough center in the medulla oblongata to effectively suppress dry, irritating coughs associated with respiratory infections, the common cold, and bronchitis.
Therapeutic Advantages & Accessibility
Unlike narcotic cough suppressants, pd NOSCA does not induce physical dependence, nor does it cause significant sedation or respiratory depression. Its superior safety profile makes it an ideal choice for patient compliance. This product is classified as an Over-the-Counter (OTC) medication, allowing for accessible and targeted relief of cough reflexes.
Packaging & Administration
Noscapine Syrup is supplied as an oral liquid, ensuring ease of administration for patients of various ages. Each unit is packaged in a 100 ml PET bottle, complete with an outer carton and a detailed patient information leaflet to ensure safe and correct dosage usage.
General Information
| Generic Name | Noscapine Syrup | |
| Brand Name | pd NOSCA | |
| Manufacturer | Parand Darou Co. |
Specification
| Dosage Form | Syrup | |
| Strength | 7 mg / 5 ml | |
| Appearance | Liquid | |
| Packaging | 100 ml PET bottle in box | |
| OTC/Prescription/Supplement | OTC | |
| Route of Administration | Oral | |
| Access Level | – | |
| Category | Dry cough suppressant |
